| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -1.1 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |